Expert Group Immuno-Oncology

​Immunotherapeutic agents are increasingly used for various tumor entities and lead to impressive reductions in metastases in some tumors. They act via the activation of immunological defense mechanisms which, however, are not specifically limited to the tumor cells, but can also attack various organs. In this context, we are increasingly observing autoimmune phenomena in different organ systems, which must be carefully assessed by the relevant experts.

An interdisciplinary expert group for immunooncology with the following members was therefore established at the University Hospital of Zurich to assist you with specific questions in these fields.












We use cookies to make our website user-friendly, to continuously improve it and to analyze the traffic of our website. By continuing to browse the site, you are agreeing to our use of cookies. Further information can be found in our privacy policy.